Cullinan Therapeutics (CGEM) Long-Term Investments (2021 - 2026)
Cullinan Therapeutics' Long-Term Investments came in at $19.02 million for Q2 2026, down 92.2% from $242.3 million a year earlier and down 50.6% from the prior quarter.
Cullinan Therapeutics (CGEM) Long-Term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Cullinan Therapeutics' Long-Term Investments was $58.27 million, down 71.5% from FY2024.
- Long-Term Investments carries a four-year compound annual growth rate of -19.7% (FY2021 to FY2025).
- Going back by year, Long-Term Investments was $204.44 million in FY2024, $80.88 million in FY2022 (-42.4%) and $140.4 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Long-Term Investments since Q3 2023.
- Year-over-year, Long-Term Investments has declined for three consecutive quarters, with growth averaging 33.3% over the last five quarters.
- The fastest year-over-year change in Long-Term Investments over five years came in Q3 2024 (growth of 274.0%), and the weakest in Q2 2026 (a decline of 92.2%).
- Business Quant data shows CGEM's Long-Term Investments at $38.5 million (Q1 2026), $58.27 million (Q4 2025) and $140 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Cullinan Therapeutics | 987.71 Mn | 987.71 Mn | - | 19.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.02 Mn |
| Mar 31, 2026 | 38.50 Mn |
| Dec 31, 2025 | 58.27 Mn |
| Sep 30, 2025 | 140.00 Mn |
| Jun 30, 2025 | 242.30 Mn |
| Mar 31, 2025 | 259.39 Mn |
| Dec 31, 2024 | 204.44 Mn |
| Sep 30, 2024 | 57.98 Mn |
| Sep 30, 2023 | 15.50 Mn |
| Jun 30, 2023 | 20.30 Mn |
| Mar 31, 2023 | 112.80 Mn |
| Dec 31, 2022 | 80.88 Mn |
| Sep 30, 2022 | 30.70 Mn |
| Jun 30, 2022 | 44.60 Mn |
| Mar 31, 2022 | 95.40 Mn |
| Dec 31, 2021 | 140.40 Mn |
| Sep 30, 2021 | 124.33 Mn |
| Jun 30, 2021 | 119.64 Mn |
| Mar 31, 2021 | 32.11 Mn |
Cullinan Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=CGEM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();